Moderna's work on the coronavirus vaccine offered it a big opportunity. I'm not talking about the opportunity to make billions of dollars in revenue on one product. That's great. But I'm talking about an opportunity that will impact its entire future. And that was the opportunity to prove its technology works. Moderna's entire pipeline is based on this messenger RNA (mRNA) technology. I am really glad that I found https://tradepicker.today/DailyTradeIdeas It will help you put various potential stocks under your watchlist, ensuring that you invest on them before they boom.
Join today and have our top stock picks, tips, and trade advice at your finger tips tomorrow!
Join today and have our top stock picks, tips, and trade advice at your finger tips tomorrow!
tradepicker.today
L
On the way to 500+
J
Mix & Match approved. I'll stick with Moderna thanks...
J
BOOSTERS APPROVED!!!
L
Earning report will be released on November 4. Q3 EPS will be $10. Whole year (2021) EPS will be $30. So if PE is 16-20, then Moderna SP should be $480-$600. Go Moderna
J
It feels like a big move up today with the Novavax non performance on manufacturing. Booster news any day and earnings coming up. We should be back over $400 or higher within days
J
Moderna plans to start a phase 3 trial for its CMV candidate this year. The company has said it expects peak annual sales for a potential product in the range of $2 billion and $5 billion. So, this could be another blockbuster for the biotech company. Big pharma Merck also has a CMV vaccine candidate in phase 2 studies. But most other players are farther behind in development. This opens the door to massive market share for Moderna.
N
FDA Authorizes Covid-19 Vaccine Boosters From Moderna- U.S. health regulators significantly widened the nation's Covid-19 booster campaign, clearing use of extra doses of Moderna Inc. and Johnson & Johnson vaccines and also saying people can get a shot that is different from what they had previously received.
The moves, announced by the Food and Drug Administration on Wednesday, will make boosters available to the majority of adults who have been fully vaccinated and have passed the recommended waiting period. The FDA, which regulates a wide range of medical products, must authorize or approve a vaccine before it can be used outside clinical trials. Once a vaccine is authorized, the CDC sets policies about whether people should get it, which groups, and on which schedule.
The NIH study showed that J&J vaccine recipients boosted with a Moderna dose saw a 76-fold increase in antibody levels, while a Pfizer booster increased antibody levels 35-fold and a J&J dose increased antibody levels fourfold.
N
BOOSTERS APPROVED!!!
1 billion extra doses: Moderna estimates that the positive vote in support of mRNA-1273 at the 50 µg dose level and subsequent approval would result in up to 1 billion extra doses being available for distribution in 2022.
X
clearly the best booster on the market, 2x better than BNTX. Given that the cost of administering a vaccine is almost as much as the vaccine itself, most countries are going to try to secure as much moderna booster as possible.
D
So I just watched a video of WH press secretary Jen Psaki speak unpleasantly about Moderna and how the company will not share info on vaccine development. It pictures Moderna as greedy. I was just curious what your thoughts are on how the company could move so that it reflects good on the company and would be ideal for stock price.
B
Booster approved… let’s see some movement back to $400
R
Fact check: Pfizer trails Moderna in vaccines donated.
“The Moderna vaccine accounts for the largest share of U.S. donated doses (see Figure 4). Of the 140 million doses provided to date, 42% are Moderna, followed by Pfizer (25%), and Johnson & Johnson (19%).Sep 22, 2021”
Moderna estimates that the positive vote in support of mRNA-1273 at the 50 µg dose level and subsequent approval would result in up to 1 billion extra doses being available for distribution in 2022.
T
Booster Approved Time for $400 then $600 after earnings.
j
With News release tonight with the vaccine approval of MRNA booster shot, Stock price is fundamentally undervalued. It's 52week high is $497.49. Technically in the charts to even revert back to its 50 day MA is $384. And we all have to deal with covid as its here to stay. People will need the vaccine annually much like the flu shot. Bullish. Good Luck
"Doctor on Covid-19: ‘This is a virus that is really here to stay’" Wed, October 20, 2021, "Dr. Elizabeth Clayborne, Adjunct Assistant Professor of Emergency Medicine at the University of Maryland School of Medicine and Emergency Physician at UM Capital Region Medical Center"
t
Dear Invisible Hand, we’re not going anywhere so you can start the march up to 500 anytime now.
B
Mix n Match booster approved MRNA
J
Anemic volume. Sellers drying up. Might be a good sign to the up side soon.
Go Moderna
U.S. health regulators significantly widened the nation's Covid-19 booster campaign, clearing use of extra doses of Moderna Inc. and Johnson & Johnson vaccines and also saying people can get a shot that is different from what they had previously received.
The moves, announced by the Food and Drug Administration on Wednesday, will make boosters available to the majority of adults who have been fully vaccinated and have passed the recommended waiting period.
The FDA, which regulates a wide range of medical products, must authorize or approve a vaccine before it can be used outside clinical trials. Once a vaccine is authorized, the CDC sets policies about whether people should get it, which groups, and on which schedule.
The NIH study showed that J&J vaccine recipients boosted with a Moderna dose saw a 76-fold increase in antibody levels, while a Pfizer booster increased antibody levels 35-fold and a J&J dose increased antibody levels fourfold.
1 billion extra doses:
Moderna estimates that the positive vote in support of mRNA-1273 at the 50 µg dose level and subsequent approval would result in up to 1 billion extra doses being available for distribution in 2022.
“The Moderna vaccine accounts for the largest share of U.S. donated doses (see Figure 4). Of the 140 million doses provided to date, 42% are Moderna, followed by Pfizer (25%), and Johnson & Johnson (19%).Sep 22, 2021”
https://www.kff.org/coronavirus-covid-19/issue-brief/tracking-u-s-covid-19-vaccine-donations/
Moderna estimates that the positive vote in support of mRNA-1273 at the 50 µg dose level and subsequent approval would result in up to 1 billion extra doses being available for distribution in 2022.
Time for $400 then $600 after earnings.
"Doctor on Covid-19: ‘This is a virus that is really here to stay’"
Wed, October 20, 2021,
"Dr. Elizabeth Clayborne, Adjunct Assistant Professor of Emergency Medicine at the University of Maryland School of Medicine and Emergency Physician at UM Capital Region Medical Center"